JP2021511388A5 - - Google Patents

Info

Publication number
JP2021511388A5
JP2021511388A5 JP2020561603A JP2020561603A JP2021511388A5 JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5 JP 2020561603 A JP2020561603 A JP 2020561603A JP 2020561603 A JP2020561603 A JP 2020561603A JP 2021511388 A5 JP2021511388 A5 JP 2021511388A5
Authority
JP
Japan
Prior art keywords
skin
ceramide
reduce
composition according
appearance
Prior art date
Application number
JP2020561603A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019147931A5 (https=
JP2021511388A (ja
JP7369716B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/015137 external-priority patent/WO2019147931A1/en
Publication of JP2021511388A publication Critical patent/JP2021511388A/ja
Publication of JPWO2019147931A5 publication Critical patent/JPWO2019147931A5/ja
Publication of JP2021511388A5 publication Critical patent/JP2021511388A5/ja
Application granted granted Critical
Publication of JP7369716B2 publication Critical patent/JP7369716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561603A 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用 Active JP7369716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862622375P 2018-01-26 2018-01-26
US62/622,375 2018-01-26
PCT/US2019/015137 WO2019147931A1 (en) 2018-01-26 2019-01-25 Use of ambroxol to improve skin barrier function

Publications (4)

Publication Number Publication Date
JP2021511388A JP2021511388A (ja) 2021-05-06
JPWO2019147931A5 JPWO2019147931A5 (https=) 2022-01-12
JP2021511388A5 true JP2021511388A5 (https=) 2022-01-12
JP7369716B2 JP7369716B2 (ja) 2023-10-26

Family

ID=65363412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561603A Active JP7369716B2 (ja) 2018-01-26 2019-01-25 皮膚バリア機能を改善するためのアンブロキソールの使用

Country Status (6)

Country Link
US (3) US10894008B2 (https=)
EP (1) EP3743039A1 (https=)
JP (1) JP7369716B2 (https=)
CN (1) CN111655223A (https=)
CA (1) CA3087079A1 (https=)
WO (1) WO2019147931A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7369716B2 (ja) * 2018-01-26 2023-10-26 ノイレ, エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用
WO2022098366A1 (en) * 2020-11-09 2022-05-12 Redwood Ip Holding, Llc Skincare compositions for preventing transepidermal water loss
JPWO2023145735A1 (https=) * 2022-01-25 2023-08-03
CN121127451A (zh) * 2023-05-02 2025-12-12 启威公司 一种用于医疗用途的改良型氨溴索

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533379A (ja) * 1998-12-23 2002-10-08 イデア アクチェンゲゼルシャフト 生体内における局所的に非侵襲性である用途のための改善された製剤
MXPA04002066A (es) 2001-09-04 2005-02-17 Techno Network Shinoku Co Ltd Farmacos contra influenza.
DE10332487A1 (de) 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
DE102004021992A1 (de) 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
JP2008520630A (ja) * 2004-11-22 2008-06-19 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト 皮膚損傷に有効なセラミド及び/又は偽セラミドと(α−)ビサボロールを含む製剤
ES2641272T3 (es) * 2006-04-28 2017-11-08 Children's Hospital Medical Center Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana
WO2008021829A2 (en) * 2006-08-09 2008-02-21 Lipo Chemicals Inc. Topical ceramide compositions and methos of use
JP5337405B2 (ja) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン ゴーシェ病の治療方法
US20110294833A1 (en) 2010-05-26 2011-12-01 Scripps Health Methods for Healthy Aging
JP5938193B2 (ja) * 2011-11-10 2016-06-22 ポーラ化成工業株式会社 抗老化剤のスクリ−ニング方法
BR112014012858B1 (pt) * 2011-11-30 2019-02-26 Ibr - Israeli Biotechnology Research Ltd. Extrato de jojoba útil em melhorar as funções de barreira da pele
JP2013241398A (ja) * 2012-04-27 2013-12-05 Fujifilm Corp β−グルコセレブロシダーゼ活性増強剤、セラミド産生増強剤及び皮膚バリア機能改善剤
TW201422246A (zh) * 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節wipi-1改善皮膚老化外觀之方法
US20180296464A1 (en) 2017-04-17 2018-10-18 W Skincare, LLC Autophagy activation nutrient complex, compositions and methods
US10179095B2 (en) 2017-06-07 2019-01-15 Dr. Raymond Laboratories Autophage activating resveratrol topical composition for skin improvement and treatment
EP3654960A1 (en) * 2017-07-16 2020-05-27 Neuere, LLC Ambroxol to improve and/or extend healthspan, lifespan and/or mental acuity
JP7369716B2 (ja) * 2018-01-26 2023-10-26 ノイレ, エルエルシー 皮膚バリア機能を改善するためのアンブロキソールの使用

Similar Documents

Publication Publication Date Title
JP2021511388A5 (https=)
US8845600B2 (en) Skin care compositions and uses thereof
US20200276094A1 (en) Compositions for skin expoliation and use thereof
EP3713583B1 (en) Methods and compositions for treatment of skin
TW201513853A (zh) 用於表皮修復和皮膚疾患治療的配方
HU218914B (hu) Eljárás cellulitis kezelésére alkalmas,hatóanyagként retinsavat vagy annak valamely sóját vagy retinolt tartalmazó gyógyszerkészítmények előállítására
JP2014521671A (ja) 皮膚および毛髪の外観を改善するためのスフィンガニンの使用
JP6842794B2 (ja) 皮膚外用製剤
JP2008500261A (ja) 抗アレルギ作用及び抗炎症作用を有する表皮剥離性組成
KR20120118064A (ko) 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물
CN106470677A (zh) 用于治疗皮肤学疾病及病症的组成物
US20200030398A1 (en) Skin care composition
US20020176876A1 (en) Topical therapeutic skin care system
KR20250163412A (ko) 스트론튬 및 메틸술포닐메탄(msm)을 포함하는 국소 제제 및 치료 방법
Vardy et al. A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrheic dermatitis
WO2016033899A1 (zh) 一种调节头皮油脂平衡的去屑组合物
JPWO2019147931A5 (https=)
JP2013531664A (ja) Spf30を有する保湿組成物
EP3195852B1 (en) Keratin softening patch
RU2722823C2 (ru) Косметический состав для лечения и профилактики акне на коже
JP2016501236A (ja) 炎症性皮膚状態の予防および治療のための方法
JPH11505238A (ja) 皮膚症状処置用組成物
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
US20040204492A1 (en) Topical composition and method for treating seborrheic dermatitis
CN118973550A (zh) 用于局部使用以预防或治疗至少一种皮肤炎症症状的超支化糊精